CAT
Caterpillar Inc.
CAT has the edge over CRGO overall, supported by lower modeled downside and stronger modeled upside.
CRGO
Freightos Limited Ordinary shares
CRGO offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
CRGO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Unavailable |
CRGO's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
CRGO PE Valuation
CRGO has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
CRGO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CRGO's losses to shrink, with revenue growing.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over CRGO on earnings quality, reporting a profit while its opponent remains loss making.
CRGO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.33 | +$0.10 |
| Q1 2026 | -$0.39 | +$0.07 |
| Q4 2025 | -$0.35 | +$0.11 |
| Q3 2025 | -$0.47 | -$0.14 |
| Q2 2025 | -$0.43 | $0.00 |
| Q1 2025 | -$0.46 | -$0.02 |
| Q4 2024 | -$0.46 | +$1.24 |
| Q3 2024 | -$0.33 | +$2.41 |
CRGO is still losing money, but far less than before: $0.33 per share over the past year, against $11.75 at its worst in late 2022.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over CRGO on profitability, with a higher operating margin.
CRGO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $7.7M | +3.4% |
| Q1 2026 | $7.2M | +3% |
| Q4 2025 | $7.4M | +12% |
| Q3 2025 | $7.7M | +24% |
| Q2 2025 | $7.4M | +31% |
| Q1 2025 | $6.9M | +30% |
| Q4 2024 | $6.6M | +25% |
| Q3 2024 | $6.2M | +21% |
CRGO has the edge over CAT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -46% | +15 points |
| Q1 2026 | -66% | +1.2 points |
| Q4 2025 | -76% | +0.5 points |
| Q3 2025 | -57% | +22 points |
| Q2 2025 | -61% | +20 points |
| Q1 2025 | -67% | +35 points |
| Q4 2024 | -76% | +12 points |
| Q3 2024 | -79% | +103 points |
CRGO's operating margin was −46% last quarter, up 15 points from the same quarter a year ago, near the top of its range since 2021.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over CRGO on cash generation, producing positive trailing cash flow while its opponent burns cash.
CRGO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.3M | +$1.5M |
| Q1 2026 | -$4.5M | -1735% |
| Q4 2025 | -$3M | +$1.6M |
| Q3 2025 | -$3.4M | -$347K |
| Q2 2025 | -$2.9M | -$107K |
| Q1 2025 | $274K | +$2M |
| Q4 2024 | -$4.5M | -$1.5M |
| Q3 2024 | -$3.1M | +$2.2M |
CRGO has burned cash in almost every quarter: −$12M over the past year, against −$10M the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over CRGO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
CRGO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +313K shares |
| 1 year | +3.1% | +1.5M shares |
| 3 years | +9.2% | +4.4M shares |
| 5 years | +734% | +45.6M shares |
CRGO has 52M diluted shares, up 3.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
CRGO hasn't bought back shares in the past year.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
CRGO Net Leverage
CRGO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CRGO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.1 | Neutral |
| Stochastic | 7.4 | Oversold |
CRGO's weekly RSI is 30 (neutral) and its Stochastic is 7 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
CRGO PE vs Industrials Sector
| Metric | CRGO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
CRGO has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over CRGO on trend strength, trading above more of its moving averages.
CRGO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.81 | 6.2% below |
| 20 week MA | $1.08 | 30% below |
| 50 week MA | $1.63 | 53% below |
| 100 week MA | $2.28 | 67% below |
| 200 week MA | $2.53 | 70% below |
CRGO is in a downtrend: it's below all five of its weekly moving averages, and 70% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over CRGO on returns for 2026, with the stronger performance.
CRGO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $9.79 | $9.78 | -0.1% |
| 2022 | $9.78 | $10.2 | +3.8% |
| 2023 | $10.2 | $3.33 | -67% |
| 2024 | $3.33 | $2.85 | -14% |
| 2025 | $2.85 | $2.32 | -19% |
| 2026 YTD | $2.32 | $0.76 | -67% |
CRGO has finished three years in a row lower, and it's down 67% so far in 2026.